Feasibility Analysis of Interleukin-13 as a Target for a Therapeutic Vaccine

Background: The development of therapeutic vaccines requires thorough knowledge of potential hazards associated with long-term inactivation of self-proteins. Among potential targets, interleukin 13 (IL-13) merits consideration, as monoclonal antibodies disrupting IL-13 signaling are proving to be ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Foerster, John, Molęda, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466196/
https://www.ncbi.nlm.nih.gov/pubmed/30759882
http://dx.doi.org/10.3390/vaccines7010020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466196/
https://www.ncbi.nlm.nih.gov/pubmed/30759882
http://dx.doi.org/10.3390/vaccines7010020

Ejemplares similares